| Patent | Date |
|---|
Target Peptides For Cancer Therapy And Diagnostics
App 20220265791 - Hunt; Donald F. ; et al. | 2022-08-25 |
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
Grant 11,414,458 - Hunt , et al. August 16, 2 | 2022-08-16 |
Target Peptides For Ovarian Cancer Therapy And Diagnostics
App 20220211828 - Hunt; Donald F. ; et al. | 2022-07-07 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis
App 20220041655 - HUNT; Donald F. ; et al. | 2022-02-10 |
Target Peptides For Colorectal Cancer Therapy And Diagnostics
App 20210154279 - Hunt; Donald F. ; et al. | 2021-05-27 |
Identification Of Mhc Class I Phospho-peptide Antigens From Breast Cancer Utilizing Shla Technology And Complementary Enrichment Strategies
App 20200399312 - HUNT; Donald F. ; et al. | 2020-12-24 |
Rapid Identification And Sequence Analysis Of Intact Proteins In Complex Mixtures
App 20200312643 - HUNT; Donald F. ; et al. | 2020-10-01 |
Target peptides for colorectal cancer therapy and diagnostics
Grant 10,682,399 - Hunt , et al. | 2020-06-16 |
Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies
Grant 10,640,535 - Hunt , et al. | 2020-05-05 |
Target Peptides For Cancer Therapy And Diagnostics
App 20190374627 - Hunt; Donald F. ; et al. | 2019-12-12 |
Identification Of Class I Mhc Associated Glycopeptides As Targets For Cancer Immunotherapy
App 20190015494 - Hunt; Donald F. ; et al. | 2019-01-17 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis
App 20180066017 - Hunt; Donald F. ; et al. | 2018-03-08 |
Target Peptides For Immunotherapy And Diagnostics
App 20170333541 - Hunt; Donald F. ; et al. | 2017-11-23 |
Target peptides for immunotherapy and diagnostics
Grant 9,561,266 - Hunt , et al. February 7, 2 | 2017-02-07 |
Phosphopeptides as melanoma vaccines
Grant 9,279,011 - Topalian , et al. March 8, 2 | 2016-03-08 |
Target Peptides For Ovarian Cancer Therapy And Diagnostics
App 20160000893 - Hunt; Donald F. ; et al. | 2016-01-07 |
Target Peptides For Colorectal Cancer Therapy And Diagnostics
App 20150328297 - Hunt; Donald F. ; et al. | 2015-11-19 |
Target Peptides For Immunotherapy And Diagnostics
App 20150224182 - Hunt; Donald F. ; et al. | 2015-08-13 |
Identification Of Mhc Class I Phospho-peptide Antigens From Breast Cancer Utilizing Shla Technology And Complementary Enrichment Strategies
App 20150225456 - Hunt; Donald F. ; et al. | 2015-08-13 |
Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof
Grant 8,758,767 - DiLorenzo , et al. June 24, 2 | 2014-06-24 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis
App 20130259883 - Hunt; Donald F. ; et al. | 2013-10-03 |
Phosphopeptides As Melanoma Vaccines
App 20120177669 - Topalian; Suzanne L. ; et al. | 2012-07-12 |
Method and apparatus for generation of reagent ions in a mass spectrometer
Grant 8,119,984 - Shabanowitz , et al. February 21, 2 | 2012-02-21 |
Method and Apparatus for Generation of Reagent Ions in a Mass Spectrometer
App 20090294649 - Shabanowitz; Jeffrey ; et al. | 2009-12-03 |
Antigens Targeted by Prevalent Pathogennic T Cells in Type 1 Diabetes and Uses Thereof
App 20080153112 - DiLorenzo; Teresa P. ; et al. | 2008-06-26 |
Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor
Grant 7,019,112 - Slingluff , et al. March 28, 2 | 2006-03-28 |
Phosphopeptide antigens associated with MHC molecules
App 20050277161 - Engelhard, Victor H. ; et al. | 2005-12-15 |
Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
Grant 6,660,276 - Slingluff , et al. December 9, 2 | 2003-12-09 |
Mhc peptides over-expressed on prostate cancer cells and methods of use
App 20030211116 - White, Forest ; et al. | 2003-11-13 |
Apparatus for producing ions of thermally labile or nonvolatile solids
Grant 4,156,814 - Hunt , et al. May 29, 1 | 1979-05-29 |
| 